Diffuse Uveal Melanocytic Proliferation With Primary Vitreoretinal Lymphoma

JAMA Ophthalmol. 2019 Jul 1;137(7):834-837. doi: 10.1001/jamaophthalmol.2019.0905.

Abstract

Importance: Bilateral diffuse uveal melanocytic proliferation is a rare sign of several systemic malignant neoplasms.

Observations: A patient presenting with uveal melanocytic proliferation underwent a detailed physical examination and extensive imaging. No systemic malignant neoplasm was found. Chorioretinal biopsy was performed, and its immunohistochemical results revealed the presence of primary vitreoretinal lymphoma.

Conclusions and relevance: This patient's results suggest that diffuse uveal melanocytic proliferation may be associated not just with systemic malignant disease, but also with primary intraocular tumors, in this case a primary vitreoretinal lymphoma.

Publication types

  • Case Reports

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use
  • Biomarkers, Tumor / metabolism
  • Cell Proliferation*
  • Female
  • Fluorescein Angiography
  • Humans
  • Infusions, Intravenous
  • Intravitreal Injections
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Lymphoma, Large B-Cell, Diffuse / metabolism
  • Lymphoma, Large B-Cell, Diffuse / pathology*
  • Melanocytes / pathology*
  • Methotrexate / therapeutic use
  • Middle Aged
  • Neoplasm Proteins / metabolism
  • Paraneoplastic Syndromes, Ocular / drug therapy
  • Paraneoplastic Syndromes, Ocular / metabolism
  • Paraneoplastic Syndromes, Ocular / pathology*
  • Retinal Neoplasms / drug therapy
  • Retinal Neoplasms / metabolism
  • Retinal Neoplasms / pathology*
  • Tomography, Optical Coherence
  • Uvea / pathology*
  • Visual Acuity / physiology
  • Vitreous Body / drug effects
  • Vitreous Body / metabolism
  • Vitreous Body / pathology*

Substances

  • Antimetabolites, Antineoplastic
  • Biomarkers, Tumor
  • Neoplasm Proteins
  • Methotrexate